AstraZeneca to Invest C$820 Million to Move to Larger Toronto Office
AstraZeneca will invest 820 million Canadian dollars, equivalent to $570.3 million, to facilitate a move to a larger office in the Toronto metro area. The Anglo-Swedish pharmaceutical giant said ...
MedPage Today7m
Injectable Anticoagulant Substantially Cuts Bleeding Risk in Afib
For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...
700 new jobs expected in company expansion in Mississauga
New jobs are coming to a Mississauga company. Officials gathered at the Mississauga-based biopharmaceutical company AstraZeneca Canada on Thursday to announce $16.1 million in funding through the ...
Monopar Therapeutics Stock Hits 52-Week High at $38.91
Monopar Therapeutics Inc . (NASDAQ:MNPR) stock soared to a 52-week high, reaching a price level of $38.91. According to ...